Cover Image
Market Research Report

Global Vascular Guidewires Market Forecast 2019-2027

Published by Inkwood Research Product code 904361
Published Content info 144 Pages
Delivery time: 2-3 business days
Price
Back to Top
Global Vascular Guidewires Market Forecast 2019-2027
Published: August 7, 2019 Content info: 144 Pages
Description

KEY FINDINGS

According to Inkwood Research, the global vascular guidewires market is expected to reach $1614.2 million by the end of 2027 and evolve around 5.46% CAGR during the estimated period of 2019-2027. The rising incidences of cardiovascular diseases along with rapid technological developments, will further drive the expansion of the market in future.

MARKET INSIGHTS

The increasing geriatric population on a global scale and growing prevalence of chronic diseases attributes to the rising demand for minimally invasive procedures, thereby propelling the growth of vascular guidewires market. Furthermore, government initiatives like awareness and educational programs result in rising awareness among people about various options available to treat cardiovascular disorders. This factors accompanied by other aspects will drive the global vascular guidewires market growth.

REGIONAL INSIGHTS

Geographically, the global vascular guidewires market has been classified into few regions, namely Europe, Asia Pacific, North America, and Rest of World regional segment that comprises of remaining countries. The North America region is anticipated to hold a significant market share of XX% during the forecast period. This market in the region is factored to better healthcare infrastructure and high adoption of vascular guidewires, and eventually boosting its market growth.

COMPETITIVE INSIGHTS

The leading companies in the market are Medtronic, Olympus Corporation, Edward Lifesciences, Biotronik Se & Co. KG, Becton Dickinson and Company, B Braun Melsungen AG, Koninklijke Philips N.V., Boston Scientific Corporation, Merit Medical Systems, Cook Medical LLC, Cardinal Health Inc., Terumo, Abbott, and GaltNeedleTech.

Table of Contents
Product Code: 26228

Table of contents

1. RESEARCH SCOPE

  • 1.1. STUDY GOALS
  • 1.2. SCOPE OF THE MARKET STUDY
  • 1.3. WHO WILL FIND THIS REPORT USEFUL?
  • 1.4. STUDY AND FORECASTING YEARS

2. RESEARCH METHODOLOGY

  • 2.1. SOURCES OF DATA
    • 2.1.1. SECONDARY DATA
    • 2.1.2. PRIMARY DATA
  • 2.2. TOP-DOWN APPROACH
  • 2.3. BOTTOM-UP APPROACH
  • 2.4. DATA TRIANGULATION

3. EXECUTIVE SUMMARY

  • 3.1. MARKET SUMMARY
  • 3.2. KEY FINDINGS
    • 3.2.1. CORONARY GUIDEWIRES ARE THE MAJORLY USED APPLICATION
    • 3.2.2. HYDROPHOBIC COATING IS THE FASTEST GROWING COATED TYPE
    • 3.2.3. HOSPITALS ARE THE HIGHEST REVENUE GENERATING END USERS

4. MARKET DYNAMICS

  • 4.1. MARKET SCOPE & DEFINITION
  • 4.2. MARKET DRIVERS
    • 4.2.1. RISE IN PREVALENCE OF CHRONIC DISEASES
    • 4.2.2. INCREASING DEMAND FOR MI PROCEDURES
    • 4.2.3. AWARENESS AMONG PATIENTS ABOUT TREATMENT OPTIONS
    • 4.2.4. PREVAILING HIGH UNMET MEDICAL NEEDS
  • 4.3. MARKET RESTRAINTS
    • 4.3.1. RISKS ASSOCIATED WITH THE USE OF GUIDEWIRES
    • 4.3.2. UNFAVORABLE PREFERENCE FOR DRUGS
    • 4.3.3. ISSUE IN LOST GUIDEWIRE RETRIEVAL
  • 4.4. MARKET OPPORTUNITIES
    • 4.4.1. TECHNOLOGICAL ADVANCEMENTS
    • 4.4.2. SURGE IN THE ADOPTION OF VASCULAR PROCEDURES
  • 4.5. MARKET CHALLENGES
    • 4.5.1. COMPLEXITIES ASSOCIATED IN THE MANUFACTURING OF VASCULAR GUIDEWIRES
    • 4.5.2. PRICING COUPLED WITH PAUCITY OF PRODUCT DIFFERENTIATION

5. MARKET BY APPLICATION

  • 5.1. CORONARY GUIDEWIRES
  • 5.2. PERIPHERAL GUIDEWIRES
  • 5.3. UROLOGICAL GUIDEWIRES
  • 5.4. NEUROVASCULAR GUIDEWIRES

6. MARKET BY COATING TYPE

  • 6.1. COATED
    • 6.1.1. HYDROPHILIC COATING
    • 6.1.2. HYDROPHOBIC COATING
  • 6.2. NON-COATED

7. MARKET BY END USER

  • 7.1. HOSPITALS
  • 7.2. AMBULATORY SURGICAL CENTERS

8. KEY ANALYTICS

  • 8.1. PORTER'S FIVE FORCES MODEL
    • 8.1.1. THREAT OF NEW ENTRANTS
    • 8.1.2. THREAT OF SUBSTITUTE PRODUCTS
    • 8.1.3. BARGAINING POWER OF BUYER
    • 8.1.4. BARGAINING POWER OF SUPPLIER
    • 8.1.5. INTENSITY OF COMPETITIVE RIVALRY
  • 8.2. VALUE CHAIN ANALYSIS
  • 8.3. REGULATORY FRAMEWORK
  • 8.4. SUPPLY CHAIN ANALYSIS
  • 8.5. PATENT ANALYSIS
  • 8.6. OPPORTUNITY MATRIX

9. GEOGRAPHICAL ANALYSIS

  • 9.1. NORTH AMERICA
    • 9.1.1. THE UNITED STATES
    • 9.1.2. CANADA
  • 9.2. EUROPE
    • 9.2.1. GERMANY
    • 9.2.2. FRANCE
    • 9.2.3. THE UNITED KINGDOM
    • 9.2.4. ITALY
    • 9.2.5. SPAIN
    • 9.2.6. REST OF EUROPE
  • 9.3. ASIA PACIFIC
    • 9.3.1. JAPAN
    • 9.3.2. CHINA
    • 9.3.3. INDIA
    • 9.3.4. AUSTRALIA
    • 9.3.5. SOUTH KOREA
    • 9.3.6. REST OF APAC
  • 9.4. REST OF WORLD
    • 9.4.1. LATIN AMERICA
    • 9.4.2. MIDDLE EAST AND AFRICA

10. COMPETITIVE LANDSCAPE

  • 10.1. MARKET SHARE ANALYSIS
  • 10.2. COMPANY PROFILES
    • 10.2.1. ABBOTT
    • 10.2.2. B BRAUN MELSUNGEN AG
    • 10.2.3. BECTON DICKINSON AND COMPANY
    • 10.2.4. BIOTRONIK SE & CO. KG
    • 10.2.5. BOSTON SCIENTIFIC CORPORATION
    • 10.2.6. CARDINAL HEALTH INC.
    • 10.2.7. COOK MEDICAL LLC
    • 10.2.8. EDWARD LIFESCIENCES
    • 10.2.9. GALTNEEDLETECH
    • 10.2.10. KONINKLIJKE PHILIPS N.V.
    • 10.2.11. MEDTRONIC
    • 10.2.12. MERIT MEDICAL SYSTEMS
    • 10.2.13. OLYMPUS CORPORATION
    • 10.2.14. TERUMO

LIST OF TABLES

  • TABLE 1 GLOBAL VASCULAR GUIDEWIRES MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 2 MAJOR COMPLICATIONS CAUSED BY GUIDEWIRES DURING ENDOVASCULAR OR STENTING PROCEDURES
  • TABLE 3 GLOBAL VASCULAR GUIDEWIRES MARKET BY APPLICATION 2019-2027 ($ MILLION)
  • TABLE 4 GLOBAL CORONARY GUIDEWIRES MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 5 GLOBAL PERIPHERAL GUIDEWIRES MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 6 GLOBAL UROLOGICAL GUIDEWIRES MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 7 GLOBAL NEUROVASCULAR GUIDEWIRES MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 8 GLOBAL VASCULAR GUIDEWIRES MARKET BY COATING TYPE 2019-2027 ($ MILLION)
  • TABLE 9 GLOBAL COATED MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 10 GLOBAL NON-COATED MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 11 GLOBAL VASCULAR GUIDEWIRES MARKET BY END USER 2019-2027 ($ MILLION)
  • TABLE 12 GLOBAL HOSPITALS MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 13 GLOBAL AMBULATORY SURGICAL CENTERS MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 14 GLOBAL VASCULAR GUIDEWIRES MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 15 NORTH AMERICA VASCULAR GUIDEWIRES MARKET BY COUNTRY 2019-2027 ($ MILLION)
  • TABLE 16 THE UNITED STATES VASCULAR GUIDEWIRES MARKET BY APPLICATION 2019-2027 ($ MILLION)
  • TABLE 17 THE UNITED STATES VASCULAR GUIDEWIRES MARKET BY COATING TYPE 2019-2027 ($ MILLION)
  • TABLE 18 THE UNITED STATES VASCULAR GUIDEWIRES MARKET BY END USER 2019-2027 ($ MILLION)
  • TABLE 19 CANADA VASCULAR GUIDEWIRES MARKET BY APPLICATION 2019-2027 ($ MILLION)
  • TABLE 20 CANADA VASCULAR GUIDEWIRES MARKET BY COATING TYPE 2019-2027 ($ MILLION)
  • TABLE 21 CANADA VASCULAR GUIDEWIRES MARKET BY END USER 2019-2027 ($ MILLION)
  • TABLE 22 EUROPE VASCULAR GUIDEWIRES MARKET BY COUNTRY 2019-2027 ($ MILLION)
  • TABLE 23 GERMANY VASCULAR GUIDEWIRES MARKET BY APPLICATION 2019-2027 ($ MILLION)
  • TABLE 24 GERMANY VASCULAR GUIDEWIRES MARKET BY COATING TYPE 2019-2027 ($ MILLION)
  • TABLE 25 GERMANY VASCULAR GUIDEWIRES MARKET BY END USER 2019-2027 ($ MILLION)
  • TABLE 26 FRANCE VASCULAR GUIDEWIRES MARKET BY APPLICATION 2019-2027 ($ MILLION)
  • TABLE 27 FRANCE VASCULAR GUIDEWIRES MARKET BY COATING TYPE 2019-2027 ($ MILLION)
  • TABLE 28 FRANCE VASCULAR GUIDEWIRES MARKET BY END USER 2019-2027 ($ MILLION)
  • TABLE 29 THE UNITED KINGDOM VASCULAR GUIDEWIRES MARKET BY APPLICATION 2019-2027 ($ MILLION)
  • TABLE 30 THE UNITED KINGDOM VASCULAR GUIDEWIRES MARKET BY COATING TYPE 2019-2027 ($ MILLION)
  • TABLE 31 THE UNITED KINGDOM VASCULAR GUIDEWIRES MARKET BY END USER 2019-2027 ($ MILLION)
  • TABLE 32 ITALY VASCULAR GUIDEWIRES MARKET BY APPLICATION 2019-2027 ($ MILLION)
  • TABLE 33 ITALY VASCULAR GUIDEWIRES MARKET BY COATING TYPE 2019-2027 ($ MILLION)
  • TABLE 34 ITALY VASCULAR GUIDEWIRES MARKET BY END USER 2019-2027 ($ MILLION)
  • TABLE 35 SPAIN VASCULAR GUIDEWIRES MARKET BY APPLICATION 2019-2027 ($ MILLION)
  • TABLE 36 SPAIN VASCULAR GUIDEWIRES MARKET BY COATING TYPE 2019-2027 ($ MILLION)
  • TABLE 37 SPAIN VASCULAR GUIDEWIRES MARKET BY END USER 2019-2027 ($ MILLION)
  • TABLE 38 ASIA PACIFIC VASCULAR GUIDEWIRES MARKET BY COUNTRY 2019-2027 ($ MILLION)
  • TABLE 39 JAPAN VASCULAR GUIDEWIRES MARKET BY APPLICATION 2019-2027 ($ MILLION)
  • TABLE 40 JAPAN VASCULAR GUIDEWIRES MARKET BY COATING TYPE 2019-2027 ($ MILLION)
  • TABLE 41 JAPAN VASCULAR GUIDEWIRES MARKET BY END USER 2019-2027 ($ MILLION)
  • TABLE 42 CHINA VASCULAR GUIDEWIRES MARKET BY APPLICATION 2019-2027 ($ MILLION)
  • TABLE 43 CHINA VASCULAR GUIDEWIRES MARKET BY COATING TYPE 2019-2027 ($ MILLION)
  • TABLE 44 CHINA VASCULAR GUIDEWIRES MARKET BY END USER 2019-2027 ($ MILLION)
  • TABLE 45 INDIA VASCULAR GUIDEWIRES MARKET BY APPLICATION 2019-2027 ($ MILLION)
  • TABLE 46 INDIA VASCULAR GUIDEWIRES MARKET BY COATING TYPE 2019-2027 ($ MILLION)
  • TABLE 47 INDIA VASCULAR GUIDEWIRES MARKET BY END USER 2019-2027 ($ MILLION)
  • TABLE 48 AUSTRALIA VASCULAR GUIDEWIRES MARKET BY APPLICATION 2019-2027 ($ MILLION)
  • TABLE 49 AUSTRALIA VASCULAR GUIDEWIRES MARKET BY COATING TYPE 2019-2027 ($ MILLION)
  • TABLE 50 AUSTRALIA VASCULAR GUIDEWIRES MARKET BY END USER 2019-2027 ($ MILLION)
  • TABLE 51 SOUTH KOREA VASCULAR GUIDEWIRES MARKET BY APPLICATION 2019-2027 ($ MILLION)
  • TABLE 52 SOUTH KOREA VASCULAR GUIDEWIRES MARKET BY COATING TYPE 2019-2027 ($ MILLION)
  • TABLE 53 SOUTH KOREA VASCULAR GUIDEWIRES MARKET BY END USER 2019-2027 ($ MILLION)
  • TABLE 54 REST OF WORLD VASCULAR GUIDEWIRES MARKET BY REGION 2019-2027 ($ MILLION)

LIST OF FIGURES

  • FIGURE 1 GLOBAL VASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)
  • FIGURE 2 INCIDENCE OF CHRONIC DISEASE IN THE UNITED STATES 2018
  • FIGURE 3 GLOBAL VASCULAR GUIDEWIRES MARKET SHARE BY APPLICATION 2018 & 2027 (%)
  • FIGURE 4 GLOBAL VASCULAR GUIDEWIRES MARKET BY CORONARY GUIDEWIRES 2019-2027 ($ MILLION)
  • FIGURE 5 GLOBAL VASCULAR GUIDEWIRES MARKET BY PERIPHERAL GUIDEWIRES 2019-2027 ($ MILLION)
  • FIGURE 6 GLOBAL VASCULAR GUIDEWIRES MARKET BY UROLOGICAL GUIDEWIRES 2019-2027 ($ MILLION)
  • FIGURE 7 GLOBAL VASCULAR GUIDEWIRES MARKET BY NEUROVASCULAR GUIDEWIRES 2019-2027 ($ MILLION)
  • FIGURE 8 GLOBAL VASCULAR GUIDEWIRES MARKET SHARE BY COATING TYPE 2018 & 2027 (%)
  • FIGURE 9 GLOBAL VASCULAR GUIDEWIRES MARKET BY COATED 2019-2027 ($ MILLION)
  • FIGURE 10 GLOBAL COATED VASCULAR GUIDEWIRES MARKET BY HYDROPHILIC COATING 2019-2027 ($ MILLION)
  • FIGURE 11 GLOBAL COATED VASCULAR GUIDEWIRES MARKET BY HYDROPHOBIC COATING 2019-2027 ($ MILLION)
  • FIGURE 12 GLOBAL VASCULAR GUIDEWIRES MARKET BY NON-COATED 2019-2027 ($ MILLION)
  • FIGURE 13 GLOBAL VASCULAR GUIDEWIRES MARKET SHARE BY END USER 2018 & 2027 (%)
  • FIGURE 14 GLOBAL VASCULAR GUIDEWIRES MARKET BY HOSPITALS 2019-2027 ($ MILLION)
  • FIGURE 15 GLOBAL VASCULAR GUIDEWIRES MARKET BY AMBULATORY SURGICAL CENTERS 2019-2027 ($ MILLION)
  • FIGURE 16 PORTER'S FIVE FORCE MODEL
  • FIGURE 17 NUMBER OF PATENTS REGISTERED YEARLY
  • FIGURE 18 NUMBER OF PATENTS BY COUNTRY
  • FIGURE 19 NUMBER OF PATENTS BY COMPANY
  • FIGURE 20 GLOBAL VASCULAR GUIDEWIRES MARKET REGIONAL OUTLOOK 2018 & 2027 (%)
  • FIGURE 21 THE UNITED STATES VASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)
  • FIGURE 22 CANADA VASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)
  • FIGURE 23 GERMANY VASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)
  • FIGURE 24 FRANCE GERIATRIC POPULATION 2012 AND 2017 (MILLIONS)
  • FIGURE 25 FRANCE VASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)
  • FIGURE 26 THE UNITED KINGDOM VASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)
  • FIGURE 27 ITALY VASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)
  • FIGURE 28 SPAIN VASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)
  • FIGURE 29 REST OF EUROPE VASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)
  • FIGURE 30 JAPAN VASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)
  • FIGURE 31 POPULATION ABOVE 65 YEARS IN JAPAN 2015 & 2050 (%)
  • FIGURE 32 CHINA VASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)
  • FIGURE 33 INDIA VASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)
  • FIGURE 34 POPULATION ABOVE 60 YEARS OF AGE 2015 & 2050 (%)
  • FIGURE 35 AUSTRALIA VASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)
  • FIGURE 36 SOUTH KOREA VASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)
  • FIGURE 37 REST OF APAC VASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)
  • FIGURE 38 LATIN AMERICA VASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)
  • FIGURE 39 MIDDLE EAST AND AFRICA VASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)
  • FIGURE 40 VASCULAR GUIDEWIRES COMPANY SHARE ANALYSIS 2018 (%)
Back to Top